CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CELLULAR BIOMEDICINE GROUP I ownership

CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 35 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$527,000
+0.2%
28,6610.0%0.00%
Q3 2020$526,000
+17.9%
28,661
-3.6%
0.00%
Q2 2020$446,000
-1.3%
29,735
+4.2%
0.00%
Q1 2020$452,000
-2.6%
28,5260.0%0.00%
Q4 2019$464,000
+9.4%
28,5260.0%0.00%
Q3 2019$424,000
-10.2%
28,5260.0%0.00%
Q2 2019$472,000
+8.0%
28,526
+13.2%
0.00%
Q1 2019$437,000
+0.9%
25,203
+2.9%
0.00%
Q4 2018$433,000
-2.7%
24,5000.0%0.00%
Q3 2018$445,000
+5.2%
24,500
+13.4%
0.00%
Q2 2018$423,000
+57.8%
21,600
-4.9%
0.00%
Q1 2017$268,000
-10.1%
22,7090.0%0.00%
Q4 2016$298,000
-9.7%
22,7090.0%0.00%
Q3 2016$330,000
+20.9%
22,7090.0%0.00%
Q2 2016$273,000
+2.2%
22,709
+58.7%
0.00%
Q1 2016$267,000
-13.3%
14,3090.0%0.00%
Q4 2015$308,000
+26.7%
14,3090.0%0.00%
Q3 2015$243,000
-54.7%
14,3090.0%0.00%
-100.0%
Q2 2015$537,00014,3090.00%
Other shareholders
CELLULAR BIOMEDICINE GROUP I shareholders Q2 2016
NameSharesValueWeighting ↓
PLATINUM INVESTMENT MANAGEMENT LTD 672,885$11,123,0000.26%
AWM Investment Company, Inc. 80,165$1,325,0000.25%
Nikko Asset Management Americas, Inc. 532,318$8,799,0000.17%
ARK Investment Management 314,378$5,197,0000.13%
Sumitomo Mitsui Trust Holdings, Inc. 528,418$8,735,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 32,100$531,0000.01%
Mizuho Securities Co. Ltd. 300$5,0000.01%
GEODE CAPITAL MANAGEMENT, LLC 148,815$2,459,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 18,629$308,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 16,100$237,0000.00%
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders